Evidence map›Paper›PMID 40492141›Full record

ArticleGlomerular diseases

Familial Kidney Disease Phenocopying Hypertensive Nephropathy.

Fezile Ozdemir, D Deren Oygar, Ahmet Behlul, Salahi Ataç, Simge Bardak, Meral Yükseliş, Gregory Papagregoriou, Apostolos Malatras, Daniel P Gale, Guy H Neild and 2 more

Abstract read
In one paragraph

Article in Glomerular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fezile OzdemirFazıl Küçük Faculty of Medicine, Eastern Mediterranean University, Famagusta, Cyprus.
D Deren OygarNephrology Department, Nicosia State Hospital, Burhan Nalbantoglu General Hospital, Nicosia, Cyprus.
Ahmet BehlulNephrology Department, Nicosia State Hospital, Burhan Nalbantoglu General Hospital, Nicosia, Cyprus.
Salahi AtaçNephrology Department, Nicosia State Hospital, Burhan Nalbantoglu General Hospital, Nicosia, Cyprus.
Simge BardakNephrology Department, Nicosia State Hospital, Burhan Nalbantoglu General Hospital, Nicosia, Cyprus.
Meral YükselişNephrology Department, Nicosia State Hospital, Burhan Nalbantoglu General Hospital, Nicosia, Cyprus.
Gregory PapagregoriouSchool of Medicine, University of Cyprus, Nicosia, Cyprus.
Apostolos MalatrasSchool of Medicine, University of Cyprus, Nicosia, Cyprus.
Daniel P GaleUCL Centre for Nephrology, University College, London, UK.
Guy H NeildUCL Centre for Nephrology, University College, London, UK.
Constantinos DeltasSchool of Medicine, University of Cyprus, Nicosia, Cyprus.
Cemal GurkanFazıl Küçük Faculty of Medicine, Eastern Mediterranean University, Famagusta, Cyprus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Familial kidney disease is common in Cyprus and previous studies have found that the majority of families have mutations in Alport syndrome genes COL4A3/4/5. We have collected data from over 50 Turkish Cypriot families in whom kidney disease appears to follow an autosomal dominant pattern, and looked for pathological variants in these genes. Methods: Probands from 55 families underwent massive parallel DNA sequencing using a glomerular gene panel for familial hematuria, and whole-exome sequencing (WES) was also performed in 22 of them. Clinical records were reviewed. Results: Likely pathogenic variants were identified in 7 of the 55 families (COL4A3 [3], COL4A4 [2], and COL4A5 [2]), leaving 48 unsolved families. Among the latter a common missense variant of uncertain significance (COL4A4:p.G545A), was present in 5 families (9.1%). In contrast to families with a pathogenic variant in COL4A3/4 and a clear glomerular phenotype the 5 families (54 patients with clinical and genetic data), manifested near dominant susceptibility with incomplete penetrance, presenting with hypertension, variable and intermittent microscopic hematuria, and minimal proteinuria, <1 g/day until the estimated glomerular filtration rate (eGFR) fell below 30 mL/min, after which it increased in some individuals. Of those over age 50, 20% had reached end-stage by median age of 66 (48-80) years. Conclusions: We describe a kidney disease with mild hypertension that is more characteristic of a tubulointerstitial disease and phenocopies hypertensive nephropathy. While the variant COL4A4:p.G545A is not responsible for a Mendelian CKD phenotype, it appears to increases the susceptibility, acting as a hypomorphic variant contributing to Alport spectrum nephropathy. Early detection and treatment with ACE inhibitors should prolong kidney survival to an age where hemodialysis is avoided.

Indexed as

Alport syndromeAutosomal dominantCOL4A4Hypertensive nephropathyTubulointerstitial disease

Identifiers

PMID40492141
PMCPMC12148318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.